140 results on '"Vetrivel, S"'
Search Results
102. Effect of Electroplated Gold Film on the Performance of a Piezoresistive Accelerometer with Stress Concentrated Tiny Beams
- Author
-
Navya Sri, R., primary, Vetrivel, S., additional, Mathew, Ribu, additional, and Ravi Sankar, A., additional
- Published
- 2015
- Full Text
- View/download PDF
103. Erratum to “Choices of Stent and Cerebral Protection in the Ongoing ACST-2 Trial: A Descriptive Study” [Eur J Vasc Endovasc Surg 53 (2017) 617–625]
- Author
-
Fraedrich, G., Rantner, B., Gizewski, E., Gruber, I., Hendriks, J., Cras, P., Lauwers, P., van Scheil, P., Vermassen, F., Van Herzeele, I., Geenens, M., Hemelsoet, D., Lerut, P., Lambrecht, B., Saad, G., Peeters, A., Bosiers, M., da Silva, E., de Luccia, N., Sitrangulo, J.C., Jr., Estenssoro, A.E.V., Presti, C., Casella, I., Monteiro, J.A.T., Campos, W., Jr., Puech-Leao, P., Petrov, V., Bachvarov, C., Hill, M., Mitha, A., Wong, J., Liu, C.-W., Bao, L., Yu, C., Cvjetko, I., Vidjak, V., Fiedler, J., Ostry, S., Sterba, L., Kostal, P., Staffa, R., Vlachovsky, R., Privara, M., Kriz, Z., Vojtisek, B., Krupa, P., Reif, M., Benes, V., Buchvald, P., Endrych, L., Prochazka, V., Kuliha, M., Otahal, D., Hrbac, T., Netuka, D., Mohapl, M., Kramier, F., Eldessoki, M., Heshmat, H., Abd-Allah, F., Palmiste, V., Margus, S., Toomsoo, T., Becquemin, J.-P., Bergeron, P., Abdulamit, T., Cardon, J.-M., Debus, S., Thomalla, G., Fiehler, J., Gerloss, C., Grzyska, U., Storck, M., LaMacchia, E., Eckstein, H.H., Söllner, H., Berger, H., Kallmayer, M., Popert, H., Zimmermann, A., Guenther, A., Klingner, C., Mayer, T., Schubert, J., Zanow, J., Scheinert, D., Banning-Eichenseer, U., Bausback, Y., Branzan, D., Braünilch, S., Lenzer, J., Schidt, A., Staab, H., Ulirch, M., Barlinn, J., Haase, K., Abramyuk, A., Bodechtel, U., Gerber, J., Reeps, C., Pfeiffer, T., Torello, G., Cöster, A., Giannoukas, A., Spanos, K., Matsagkas, M., Koutias, S., Vasdekis, S., Kakisis, J., Moulakakis, K., Lazaris, A., Liapas, C., Brountzos, E., Lazarides, M., Ioannou, N., Polydorou, A., Fulop, B., Fako, E., Voros, E., Bodosi, M., Nemeth, T., Barzo, P., Pazdernyik, S., Entz, L., Szeberin, Z., Dosa, E., Nemes, B., Jaranyi, Z., Pazdernyia, S., Madhaban, P., Hoffman, A., Nikolsky, E., Beyar, R., Casana, R., Tolva, V., Silingardi, R., Lauricella, A., Coppi, G., Nicoloci, E., Tusini, N., Strozzi, F., Vecchiati, E., Ferri, M., Ferrero, E., Psacharopulo, D., Gaggiano, A., Viazzo, A., Farchioni, L., Parlani, G., Caso, V., De Rangoy, P., Verzini, F., Castelli, P., DeLodovici, M.L., Carrafiello, G., Ierardi, A.M., Piffaretti, G., Nano, G., Occhiuto, M.T., Malacrida, G., Tealdi, D., Steghter, S., Stella, A., Pini, R., Faggioli, G., Sacca, S., Negri, M.D., Palombo, M., Perfumo, M.C., Fadda, G.F., Kasemi, H., Cernetti, C., Tonello, D., Visonà, A., Mangialardi, N., Ronchey, S., Altavista, M.C., Michelagnoli, S., Chisci, E., Speziale, F., Capoccia, L., Veroux, P., Giaquinta, A., Patti, F., Pulli, R., Boggia, P., Angiletta, D., Amatucci, G., Spinetti, F., Mascoli, F., Tsolaki, E., Civilini, E., Reimers, B., Setacci, C., Pogany, G., Odero, A., Accrocca, F., Bajardi, G., Takashi, I., Masayuki, E., Hidenori, E., Aidashova, B., Kospanov, N., Bakke, S., Skjelland, M., Czlonkowska, A., Kobayashi, A., Proczka, R., Dowzenko, A., Czepel, W., Polanski, J., Bialek, P., Ozkinis, G., Snoch-Ziólkiewicz, M., Gabriel, M., Stanisic, M., Iwanowski, W., Andziak, P., Gonçalves, F.B., Starodubtsev, V., Ignatenko, P., Karpenko, A., Radak, D., Aleksic, N., Sagic, D., Davidovic, L., Koncar, I., Tomic, I., Colic, M., Bartkoy, D., Rusnak, F., Gaspirini, M., Praczek, P., Milosevic, Z., Flis, V., Bergauer, A., Kobilica, N., Miksic, K., Matela, J., Blanco, E., Guerra, M., Riambau, V., Gillgren, P., Skioldebrand, C., Nymen, N., Berg, B., Delle, M., Formgren, J., Kally, T.B., Qvarfordt, P., Plate, G., Pärson, H., Lindgren, H., Bjorses, K., Gottsäter, A., Warvsten, M., Kristmundsson, T., Forssell, C., Malina, M., Holst, J., Kuhme, T., Sonesson, B., Lindblad, B., Kolbel, T., Acosta, S., Bonati, L., Traenka, C., Mueller, M., Lattman, T., Wasner, M., Mujagic, E., Von Hessling, A., Isaak, A., Stierli, P., Eugster, T., Mariani, L., Stippich, C., Wolff, T., Kahles, T., de Borst, G.J., Toorop, R., Moll, F., Lo, R., Meershoek, A., Jahrome, A.K., Vos, A.W.F., Schuiling, W., Keunen, R., Reijnen, M., Macsweeney, S., McConachie, N., Southam, A., Stansby, G., Lees, T., Lambert, D., Clarke, M., Wyatt, M., Kappadath, S., Wales, L., Jackson, R., Raudonaitis, A., MacDonald, S., Dunlop, P., Brown, A., Vetrivel, S., Bajoriene, M., Gopi, R., McCollum, C., Wolowczyk, L., Ghosh, J., Seriki, D., Ashleigh, R., Butterfield, J., Welch, M., Smyth, J.V., Briley, D., Schulz, U., Perkins, J., Hands, L., Kuker, W., Darby, C., Handa, A., Sekaran, L., Poskitt, K., Bulbulia, R., Morrison, J., Guyler, P., Grunwald, I., Brown, J., Jakeways, M., Tysoe, S., Hargroves, D., Gunathilagan, G., Insall, R., Senaratne, J., Beard, J., Cleveland, T., Nawaz, S., Lonsdale, R., Turner, D., Gaines, P., Nair, R., Chetter, I., Robinson, G., Akomolafe, B., Hatfield, J., Saastamoinen, K., Crinnion, J., Egun, A.A., Thomas, J., Drinkwater, S., D'Souza, S., Thomson, G., Gregory, B., Babu, S., Ashley, S., Joseph, T., Gibbs, R., Tebit, G., Mehrzad, A., Enevoldson, P., Mendalow, D., Parry, A., Tervitt, G., Clifton, A., Nazzel, M., Halliday, A., Peto, R., Pan, H., Potter, J., Bullbulia, R., Mihaylova, B., Flather, M., Mansfield, A., Simpson, D., Thomas, D., Gray, W., Farrell, B., Davies, C., Rahimi, K., Gough, M., Cao, P., Rothwell, P., Belli, A., Mafham, M., Herrington, W., Sandercock, P., Gray, R., Shearman, C., Molyneux, A., Gray, A., Clarke, A., Sneade, M., Tully, L., Brudlo, W., Lay, M., Munday, A., Berry, C., Tochlin, S., Cox, J., Kurien, R., Chester, J., de Waard, D.D., Huibers, A., and Bonati, L.H.
- Published
- 2017
- Full Text
- View/download PDF
104. Groin complications following femoral artery surgery. A retrospective audit
- Author
-
Hamza, N., primary, Banerjee, B., additional, Overbeck, K., additional, Brown, A., additional, Dunlop, P., additional, and Vetrivel, S., additional
- Published
- 2014
- Full Text
- View/download PDF
105. A Study on Antecedents and Consequences of Customer Satisfaction in Commercial Banks
- Author
-
Vetrivel, S.C., Krishnamoorthy, V, and Mohanasundari, M.
- Published
- 2019
106. Development of navigation system for autonomous vehicle
- Author
-
Sivaraj, D., primary, Kandaswamy, A., additional, and Vetrivel, S., additional
- Published
- 2012
- Full Text
- View/download PDF
107. Growth and Characterization of Zinc Doped L-Proline Cadmium Chloride Single Crystals
- Author
-
Vetrivel, S., primary and Rajasekaran, R., additional
- Published
- 2012
- Full Text
- View/download PDF
108. Retrograde popliteal approach to common femoral vein stenosis in an intravenous drug user with hostile groin: a case report
- Author
-
Mohamed, Z. K, primary, Banerjee, B., additional, Brown, A. S, additional, Dunlop, P., additional, England, S. J P, additional, Overbeck, K., additional, and Vetrivel, S., additional
- Published
- 2009
- Full Text
- View/download PDF
109. Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif
- Author
-
Mishra, Mamata, primary, Vetrivel, S., additional, Siddappa, Nagadenahalli B., additional, Ranga, Udaykumar, additional, and Seth, Pankaj, additional
- Published
- 2008
- Full Text
- View/download PDF
110. A Comparative Study on the Catalytic Activity of Mn Containing MCM-41 Molecular Sieves for Oxidation of p-Cymene
- Author
-
Vetrivel, S., primary and Pandurangan, A., additional
- Published
- 2007
- Full Text
- View/download PDF
111. Supported Metal Oxide Catalysts: Their Activity to Vapor Phase Oxidation of Ethylbenzene
- Author
-
Vetrivel, S., primary and Pandurangan, A., additional
- Published
- 2005
- Full Text
- View/download PDF
112. Socio-Economic Survey on Management of Poultry Production in Rural Areas.
- Author
-
VETRIVEL, S. C.
- Subjects
EGGS ,MEAT ,POULTRY products ,POULTRY research ,RURAL geography - Abstract
Poultry egg and meat is an important source of high-quality proteins, minerals and vitamins required to balance the human diet, specially developed varieties of chicken are now available with the trait of quick growth and high feed conversion efficiency. A majority of the poultry products available for consumption in Tamil Nadu come from rural poultry production in spite of the dearth of knowledge on their statistics, production, management practices, disease control methods and level of government intervention in the business. The need to obtain baseline information on the availability of rural poultry under the village conditions in Namakkal area formed the basis of the study. The study investigated production systems and reproductive performance of village chicken in rural areas surrounding Namakkal town, Tamil Nadu state. Data used were collected from rural poultry farmers in the Namakkal district using structured questionnaires and were analysed by means of simple average and percentages. The study revealed that men dominated (93.3 per cent) rural poultry production. Middle-age persons dominated the study area compared to other age groups (45.9 vs 25.8 and 28.3 per cent). Married people were engaged in rural poultry production (87.8 per cent). Majority of the poultry farmers in rural areas had school-level education (51.3 per cent). Likewise, farm ownership of the rural areas was by sole proprietors (78.6 per cent) and partnership (21.4 per cent). Relevant solutions centring on dedicated support from government are suggested. [ABSTRACT FROM AUTHOR]
- Published
- 2014
113. A comparison of duplex scanning and continuous wave Doppler in the assessment of primary and uncomplicated varicose veins
- Author
-
Darke, S.G., primary, Vetrivel, S., additional, Foy, D.M.A., additional, Smith, S., additional, and Baker, S., additional
- Published
- 1997
- Full Text
- View/download PDF
114. Audio Transcoding Using Covered Compression Scheme on Heterogenous Compressed Domain.
- Author
-
Vetrivel, S. and Athisha, G.
- Subjects
TRANSCODING ,HETEROGENEOUS computing ,DISCRETE cosine transforms ,DATA transmission systems ,FORWARD-backward algorithm ,BIT error rate - Abstract
With the recent advancement in audio transcoding, the multimedia telecommunication services are predictable to use pre-encoded audio for storage and transmission. The major concern related to transcoding B-picture to P-picture from MPEG-2 to H.263 are that the incoming discrete consine transform (DCT) coefficients of B-picture are predicted from the forward and backward predictions whereas the prediction error in the DCT domain occurring from the previous frame are not available. This requires the new prediction errors to be re-estimated resulting in high complexity not only during the heterogeneous compressed domain process but also while re-estimatng the new errors. To provide an elegant solution to the predicted errors and to perform heterogeneous compessed domain, an innovative approach called as the Covered Coding Technique based on Ascendable Sub-band Coding (CCASC) for encoding and decoding audio frames for real time transmission is presented. The objective of the research is to support heterogeneous domain with a single bit-stream, from which a number of sub-streams of varying bit-rates are extracted. A muticast transmission is introduced, where the dissimilar receivers are capable of receiving different bit rate streams from the same source in an efficient and scalable way. The multi rate property of CC-ASC also allows us to provide elegant solution to the predicted errors in the frequency domain when used over networks which support multiple priorities. [ABSTRACT FROM AUTHOR]
- Published
- 2013
115. Impact of Group-Based Microfinance on Rural Households in India.
- Author
-
Chandrakumarmangalam, S. and Vetrivel, S. C.
- Subjects
MICROFINANCE ,EMPLOYMENT ,LITERACY ,ECONOMETRIC models ,HOUSEHOLDS ,FINANCE - Abstract
The present study is empirical in nature and was carried out to assess the impact of group-based microfinance on income, assets position, savings, employment, literacy and migration of the household. A quasi-experimental design was made where the target and control groups were randomly sampled from the population. The target group was compared with the control group across various variables and the mean difference was found. The results were validated by statistical test for significance and econometric models. The test of significance between the mean for target and control groups was tested through a paired t-test. Models like Ordinary Least Squares (OLS), logistic regression and probit regression were employed to measure the impact of group-based microfinance intervention. Household was taken as the unit of analysis. The study concluded that the group-based microfinance impacted the client household positively in the increase of income, assets position, savings and literacy, and in the reduction of migration. [ABSTRACT FROM AUTHOR]
- Published
- 2012
116. Oxidative property of Nb-containing MCM-41 molecular sieves for vapor phase oxidation ofm-toluidine.
- Author
-
Vetrivel, S. and Pandurangan, A.
- Subjects
CATALYSIS ,TOLUENE ,AMINOBENZOIC acids ,SPECTRUM analysis ,RESONANCE ,SEPARATION (Technology) - Abstract
Mesoporous Nb-MCM-41 molecular sieves (Si/Nb = 50 and 75) were synthesized hydrothermally. As-synthesized and calcined catalysts were characterized by low angle X-ray powder diffraction (XRD), N
2 -adsorption isotherm, thermogravimetric and FT-IR techniques. The niobium impregnated MCM-41 catalysts were also prepared by wet method and their structure was elucidated XRD and FT-IR spectroscopy. Electron spinning resonance (ESR) studies conformed the co-ordination environment of niobium in both type of catalysts. The catalytic activity of the above catalysts was studied for the vapor phase oxidation ofm-toluidine with CO2 -free air at 200, 250, 300, 350, 400 °C. The major products werem-aminobenzoic acid andm-aminobenzaldehyde. Them-toluidine conversion was found to be higher in niobium impregnated catalysts than incorporated catalysts. The selectivity tom-aminobenzoic acid, which was the principally aimed product in this study, was found to be higher than that of them-aminobenzaldehyde. The activities of catalysts follow the order Nb-MCM-41 (1%)>Nb-MCM-41 (2%)>Nb-MCM-41 (3%)>Nb-MCM-41 (50)>Nb-MCM-41 (75). The effect of weight hourly space velocity and time on stream was also studied on conversion and products selectivity and the results are discussed. Conditions were optimized for betterm-toluidine conversion and products selectivity. [ABSTRACT FROM AUTHOR]- Published
- 2005
- Full Text
- View/download PDF
117. Virtual ERIGrid Final Conference
- Author
-
Strasser, Thomas I., Babazadeh, Davood, Heussen, Kai, Pelegrino, Luigi, Arnold, Gunter, Nguyen, Van Hoa, Palensky, Peter, Kotsampopoulos, Panos, Kontou, Alkistis, Hatziargyriou, Nikos, Narayan, Anand, Rodríguez, J. Emilio, Ulasenka, Alena, Villa, Luiz F. L., Papadimitriou, Christina, Vogel, Steffen, Rajkumar, Vetrivel S., Nguyen, Ha Thi, Stevic, Marija, Bhandia, Rishabh, Monti, Antonello, Sirviö, Katja, Roggo, Dominique, and M'Rabet, Dilan Ben
- Subjects
Research Infrastructure ,Validation ,Holistic Test Description ,Learning ,Training ,Smart grids ,Cyber-Physical Energy Systems ,7. Clean energy ,Education - Abstract
Coming to an end in April 2020, the ERIGrid project organised its Virtual Final Conference dedicated to presenting the outcomes of the 5 years of work towards the integrated research infrastructure for smart grid systems. The project consortium presented the ERIGrid holistic testing approach for validating cyber-physical energy systems and other outstanding achievements on April 1, 2020. ERIGrid’s free access to Europe’s leading laboratories (Transnational Access) has also been covered, i.e., successful users presented their energy efficient solutions that they tested at the labs of ERIGrid partners. The following presentations have been provided: Session “ERIGrid Achievements“ Welcome and ERIGrid Overview System-level Testing Approach Laboratory Coupling Approach Laboratory and Hardware-in-the-Loop based Assessment Methods Simulation-based Assessment Methods Education and Training Methods and Tools Outlook ERIGrid 2.0 Session “Facilitating Effective Laboratory Testing by Lab Users” Overview of Achievements of the ERIGrid Transnational Access Programme Application of OLTC Transformer and Distributed Generation for Voltage Control on Low Voltage Distribution Networks Datalogging, Power Converters and Machine Learning: How ERIGRID has kick started my research on planned perennity in microgrids Hardware-in-the-Loop Modelling, Simulation and Closed-Loop Testing of a distribution integrated PV Plant VILLAS4ERIGrid: Geographically Distributed Real-time Simulation and PHIL between TU Delft, DTU Risø, Lyngby and RWTH Aachen Extensive Impacts of SunHILL Impact of Time variant Grid Impedance on Power Line Communication System
118. D-NA4.2 Common Reference Test Case Profiles
- Author
-
Raussi, Petra, Opas, Mikael, Strasser, Thomas I., Widl, Edmund, Kazmi, Jawad, Hoang, Tran T., Tran, Quoc T., Rikos, Evangelos, Khavari, Ata, Heussen, Kai, Gehrke, Oliver, Paspatis, Alexandros, Gilbert, Ian, Castro, Felipe, Kamsamrong, Jirapa, Pellegrino, Luigi, Zerihun, Tesfaye A., and Rajkumar, Vetrivel S.
- Subjects
Deliverable ,13. Climate action ,Holistic Test Description ,ERIGrid 2.0 ,Test Case Profile ,Functional Scenario ,H2020 ,Project ,European Union (EU) ,7. Clean energy ,GA 870620 - Abstract
Transforming an existing energy system to an intelligent system, a so-called smart grid, requiresa multidisciplinary approach because of its complexity involving Information and Communications Technology (ICT) integration, amongst others. The technical challenges arise on how tointegrate the new technology into the existing system considering the interoperability and performance.This requires new solutions involving testing scenarios, technology development,validation processes, and roll-out procedures. The ERIGrid 2.0 project aims to enhance theresearch infrastructures’ capabilities and supports the research and technology developmenttowards smart energy systems in Europe. This necessitates system-level testing before furtherdeployment and roll-out. New innovative testing scenarios, Use Case (UC) and Test Case (TC)need to be developed, extended, updated, and shared with researchers and practitioners. This report presents the “Common Reference Test Case Profiles” to serve as the referenceTCs in the ERIGrid 2.0 project and also facilitates their application for interested external partners. Functional Scenario (FS) are used to define a high-level description of the TC. There aretwenty-five TCs developed in the project which are mapped using the six FSs: 1) ancillary services provided by Distributed Energy Resources (DERs) and active grid assets, 2) microgridsand energy community, 3) sector coupling, 4) frequency and voltage stability, 5) aggregationand flexibility management, and 6) digitalisation. These six FSs can cover a significant proportion of relevant aspects of a multi-domain cyber-physical energy system. To facilitate the implementation at Research Infrastructures (RIs), The Holistic Test Description (HTD) approach from the predecessor project ERIGrid is used to formulate the TC, forinstance the system description, System under Test (System under Test (SuT)), Object underInvestigation (OuI), Domain under Investigation (DuI), Use Case (UC) and Purpose of Investigation (PoI). In addition, each TC is defined with keywords to define the characteristics ofthe technological area, which is useful for the users to select the specific TC. The keywordsare defined corresponding to four relevant dimensions: 1) domain under investigation, 2) the phenomenon under test, 3) type of assessment, and 4) test system/component. Each TC isindividually presented as a document with the HTD template. The TCs serves as the reference pool within and beyond ERIGrid 2.0 by providing, for example, identifying key uncertainties for developing various validation approaches, demonstrationof the method for the coupling of real-time/co-simulation and Hardware-in-the-Loop (HIL) aswell as approaches for setting up the experiment and collaborate with other RIs, projects, andinitiatives.
119. D-NA4.2 Common Reference Test Case Profiles
- Author
-
Raussi, Petra, Opas, Mikael, Strasser, Thomas I., Widl, Edmund, Kazmi, Jawad, Hoang, Tran T., Tran, Quoc T., Rikos, Evangelos, Khavari, Ata, Heussen, Kai, Gehrke, Oliver, Paspatis, Alexandros, Gilbert, Ian, Castro, Felipe, Kamsamrong, Jirapa, Pellegrino, Luigi, Zerihun, Tesfaye A., and Rajkumar, Vetrivel S.
- Subjects
Deliverable ,13. Climate action ,Holistic Test Description ,ERIGrid 2.0 ,Test Case Profile ,Functional Scenario ,H2020 ,Project ,European Union (EU) ,7. Clean energy ,GA 870620 - Abstract
Transforming an existing energy system to an intelligent system, a so-called smart grid, requires a multidisciplinary approach because of its complexity involving Information and Communications Technology (ICT) integration, amongst others. The technical challenges arise on how to integrate the new technology into the existing system considering the interoperability and performance. This requires new solutions involving testing scenarios, technology development, validation processes, and roll-out procedures. The ERIGrid 2.0 project aims to enhance the research infrastructures��� capabilities and supports the research and technology development towards smart energy systems in Europe. This necessitates system-level testing before further deployment and roll-out. New innovative testing scenarios, Use Case (UC) and Test Case (TC) need to be developed, extended, updated, and shared with researchers and practitioners. This report presents the ���Common Reference Test Case Profiles��� to serve as the reference TCs in the ERIGrid 2.0 project and also facilitates their application for interested external partners. Functional Scenario (FS) are used to define a high-level description of the TC. There are twenty-five TCs developed in the project which are mapped using the six FSs: 1) ancillary services provided by Distributed Energy Resources (DERs) and active grid assets, 2) microgrids and energy community, 3) sector coupling, 4) frequency and voltage stability, 5) aggregation and flexibility management, and 6) digitalisation. These six FSs can cover a significant proportion of relevant aspects of a multi-domain cyber-physical energy system. To facilitate the implementation at Research Infrastructures (RIs), The Holistic Test Description (HTD) approach from the predecessor project ERIGrid is used to formulate the TC, for instance the system description, System under Test (System under Test (SuT)), Object under Investigation (OuI), Domain under Investigation (DuI), Use Case (UC) and Purpose of Investigation (PoI). In addition, each TC is defined with keywords to define the characteristics of the technological area, which is useful for the users to select the specific TC. The keywords are defined corresponding to four relevant dimensions: 1) domain under investigation, 2) the phenomenon under test, 3) type of assessment, and 4) test system/component. Each TC is individually presented as a document with the HTD template. The TCs serves as the reference pool within and beyond ERIGrid 2.0 by providing, for example, identifying key uncertainties for developing various validation approaches, demonstration of the method for the coupling of real-time/co-simulation and Hardware-in-the-Loop (HIL) as well as approaches for setting up the experiment and collaborate with other RIs, projects, and initiatives.
120. Interactive high quality video streaming via coequal support video transcoder
- Author
-
Vetrivel, S. and Athisha G
121. D-JRA1.1 Benchmark Scenarios
- Author
-
D'Arco, Salvatore, De Paola, Antonio, Widl, Edmund, Rajkumar, Vetrivel S., Kamsamrong, Jirapa, Raussi, Petra, Arnold, Gunter, Thomas, Dimitrios, Marinopoulos, Antonios, Wild, Christopher W., Heussen, Kai, Rikos, Evangelos, Hoang, Tran T., and Cort��s-Borray, Andr��s F.
- Subjects
Deliverable ,Reference Implementation ,ERIGrid 2.0 ,H2020 ,Scenario ,Project ,European Union (EU) ,Benchmark ,7. Clean energy ,GA 870620 - Abstract
This document presents results from the ���Benchmark Scenarios��� activity conducted in the ERI-Grid 2.0 project. The main objective of this activity is to establish reference benchmarks for validating concepts and implementations of smart grid technologies to be further used in the ERIGrid 2.0 project and by interested external users. Benchmark configurations are very valuable instruments for providing a comparative assessment of new technological approaches and implementations. Based on the Functional Scenarios (FSs) previously defined as the high-level scenarios in ERIGrid 2.0 to provide system descriptions, corresponding Use Case (UC) and Test Case (TC) descriptions, and experimental setup descriptions, this document presents the three benchmark configurations that have been defined and the ready-to-use numerical models that have been developed. The benchmarks are independent and each benchmark targets one or more FSs. The first benchmark consists of a microgrid configuration with relatively high penetration of power electronics conversion and includes several renewable energy sources. The second benchmark represents a multi-carrier energy system linking thermal and electrical distribution networks through a power-to-heat facility. Finally, the third benchmark models a smart grid with an explicit representation of the Information and Communication Technology (ICT) layer. An overview of the three benchmarks developed within ERIGrid 2.0 is provided below. Name Domain Simulation Environment Electrical Network Electrical MathWorks MATLAB/Simulink Multi-Energy Networks Electrical, Thermal pandapower, Modelica, Python ICT-Enhanced Power Systems Electrical, ICT DIgSILENT PowerFactory, Mininet The present document provides a brief summary of these three benchmarks organised in separate sections. Each of these sections includes the main motivation for the benchmark configuration, the general structure of the considered system, and examples of use. Finally, recommendations for better use and known limitations are reported. The intention of this work is to provide an overview to the interested reader without duplicating the information contained in the Preparing Concise Information for Simulation Experiments (PreCISE) templates that should be considered as the main source of documentation of these benchmarks. In this perspective, this document contains the reference directing to the PreCISE documents for a more comprehensive and exhaustive description template of the experiment regardless of the tools and models. The corresponding models and documentation are available at an Open Access (OA)/Open Source (OS) repository.
122. Crystal growth, spectral and thermal analyses of a semi organic nonlinear optical single crystal: L-tyrosine hydrochloride
- Author
-
Anandan, P., Vetrivel, S., Karthikeyan, S., Jayavel Ramasamy, and Ravi, G.
123. D-JRA1.1 Benchmark Scenarios
- Author
-
D'Arco, Salvatore, De Paola, Antonio, Widl, Edmund, Rajkumar, Vetrivel S., Kamsamrong, Jirapa, Raussi, Petra, Arnold, Gunter, Thomas, Dimitrios, Marinopoulos, Antonios, Wild, Christopher W., Heussen, Kai, Rikos, Evangelos, Hoang, Tran T., and Cortés-Borray, Andrés F.
- Subjects
Deliverable ,Reference Implementation ,ERIGrid 2.0 ,H2020 ,Scenario ,Project ,European Union (EU) ,Benchmark ,7. Clean energy ,GA 870620 - Abstract
This document presents results from the “Benchmark Scenarios” activity conducted in the ERI-Grid 2.0 project. The main objective of this activity is to establish reference benchmarks for validating concepts and implementations of smart grid technologies to be further used in the ERIGrid 2.0 project and by interested external users. Benchmark configurations are very valuable instruments for providing a comparative assessment of new technological approaches and implementations. Based on the Functional Scenarios (FSs) previously defined as the high-level scenarios in ERIGrid 2.0 to provide system descriptions, corresponding Use Case (UC) and Test Case (TC) descriptions, and experimental setup descriptions, this document presents the three benchmark configurations that have been defined and the ready-to-use numerical models that have been developed. The benchmarks are independent and each benchmark targets one or more FSs. The first benchmark consists of a microgrid configuration with relatively high penetration of power electronics conversion and includes several renewable energy sources. The second benchmark represents a multi-carrier energy system linking thermal and electrical distribution networks through a power-to-heat facility. Finally, the third benchmark models a smart grid with an explicit representation of the Information and Communication Technology (ICT) layer. An overview of the three benchmarks developed within ERIGrid 2.0 is provided below. Name Domain Simulation Environment Electrical Network Electrical MathWorks MATLAB/Simulink Multi-Energy Networks Electrical, Thermal pandapower, Modelica, Python ICT-Enhanced Power Systems Electrical, ICT DIgSILENT PowerFactory, Mininet The present document provides a brief summary of these three benchmarks organised in separate sections. Each of these sections includes the main motivation for the benchmark configuration, the general structure of the considered system, and examples of use. Finally, recommendations for better use and known limitations are reported. The intention of this work is to provide an overview to the interested reader without duplicating the information contained in the Preparing Concise Information for Simulation Experiments (PreCISE) templates that should be considered as the main source of documentation of these benchmarks. In this perspective, this document contains the reference directing to the PreCISE documents for a more comprehensive and exhaustive description template of the experiment regardless of the tools and models. The corresponding models and documentation are available at an Open Access (OA)/Open Source (OS) repository.
124. Synthesis and characterization of antibacterial activities nickel doped cobalt oxide nano particles.
- Author
-
Mayakannan, M., Gopinath, S., and Vetrivel, S.
- Subjects
- *
COBALT oxides , *HIGH resolution electron microscopy , *FOURIER transform infrared spectroscopy , *COBALT , *X-ray powder diffraction , *NICKEL - Abstract
In this paper, synthesis of pure cobalt oxide and Ni-doped cobalt oxide nano particles by microwave irradiation method and their characterization was analyzed and reported. These nano particles were analyzed by powder X-ray diffraction, Fourier transform infrared spectroscopy, high resolution scanning electron microscopy (HRSEM) and energy dispersive spectrum (EDS), transmission electron microscopy (TEM). The powder X-ray diffraction pattern showed the cubic phase structure with crystalline size of 36 nm, 25 nm, 17 nm, 26 nm. It is also confirmed by TEM morphological analysis. UV–vis NIR spectral analysis shows optical band gap decreases and shifted from E g = 5.57 eV–3.71 eV due to doping of Ni. Fluorescence spectrum shows emission wavelength at 625 nm that indicates a strong red shift. The antibacterial activity of the samples infers that among all the samples the 20% nickel doped cobalt oxide nano particles possess better activity. Image 1010 • XRD revealed the crystallite sizes of pure and Ni -Co 3 O 4 nanostructure. • FT-IR revealed the functional groups and formation of Ni-Co 3 O 4 nano particles. • TEM morphology Ni-Co 3 O 4 conformed spherical and cubic shape particles. • UV-vis NIR spectral analysis shows optical band gap value decreases E g = 5.57 eV to 3.71 eV due to doping of Ni. • Antibacterial activities shows better activity of 20 wt% Nickel doped cobalt oxide nano particles inhibit growth suitable for nano antibiotic application. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
125. Investigation on synthesis, optical and electrical performance of L-asparagine cerium(III) sulfate single crystal for non linear optical applications.
- Author
-
Suresh, T., Gopinath, S., Vinoth, E., and Vetrivel, S.
- Subjects
- *
SINGLE crystals , *SECOND harmonic generation , *CERIUM , *LASER damage , *DIELECTRIC loss , *INDIUM gallium zinc oxide - Abstract
[Display omitted] • The LACe crystal was grown by slow evaporation method. • The lower cut off wavelength is at 226 nm and Eg is 5.36 eV • The crystal has a high laser damage threshold at 42.78 J/cm2. • The SHG efficiency was found to be 8 times that of KDP. • The LACe crystal was suitable for photonic and non-linear optical (NLO) devices. In this work, L-asparagine cerium (III) sulfate bulk single crystal was successfully grown by conventional slow evaporation technique. The crystallographic data of LACe was analyzed by single crystal XRD technique and it belongs to orthorhombic system. The crystalline nature also studied. The grown crystal optical transmittance and absorption were determined by UV–vis-NIR study and various optical parameters were analyzed based on the obtained data. Fluorescence spectrum exhibits green and red emission occurred at 546 nm and 616 nm. The second harmonic generation efficiency was studied and it was found to be approximately 8 times higher than that of KDP. Light dependent photoconductivity study exhibits positive photoconductive nature. The dielectric constant (ℇ') and dielectric loss (tanδ) were measured as function of frequency. The thermal behavior and decomposition mechanism was determined by means of TG-DTA and mechanical stability was analyzed by using Vickers microhardness tester. The above characteristics studies reveal that the grown crystal is suitable for photonic and non-linear optical (NLO) device applications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
126. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy
- Author
-
Alison Halliday, Richard Bulbulia, Leo H Bonati, Johanna Chester, Andrea Cradduck-Bamford, Richard Peto, Hongchao Pan, John Potter, Hans Henning Eckstein, Barbara Farrell, Marcus Flather, Averil Mansfield, Boby Mihaylova, Kazim Rahimi, David Simpson, Dafydd Thomas, Peter Sandercock, Richard Gray, Andrew Molyneux, Cliff P Shearman, Peter Rothwell, Anna Belli, Will Herrington, Parminder Judge, Peter Leopold, Marion Mafham, Michael Gough, Piergiorgio Cao, Sumaira MacDonald, Vasha Bari, Clive Berry, S Bradshaw, Wojciech Brudlo, Alison Clarke, Robin Cox, Susan Fathers, Kamran Gaba, Mo Gray, Elizabeth Hayter, Constance Holliday, Rijo Kurien, Michael Lay, Steffi le Conte, Jessica McManus, Zahra Madgwick, Dylan Morris, Andrew Munday, Sandra Pickworth, Wiktor Ostasz, Michiel Poorthuis, Sue Richards, Louisa Teixeira, Sergey Tochlin, Lynda Tully, Carol Wallis, Monique Willet, Alan Young, Renato Casana, Chiara Malloggi, Andrea Odero Jr, Vincenzo Silani, Gianfranco Parati, Giuseppe Malchiodi, Giovanni Malferrari, Francesco Strozzi, Nicola Tusini, Enrico Vecchiati, Gioacchino Coppi, Antonio Lauricella, Roberto Moratto, Roberto Silingardi, Jessica Veronesi, Andrea Zini, Emanuele Ferrero, Michelangelo Ferri, Andrea Gaggiano, Carmelo Labate, Franco Nessi, Daniele Psacharopulo, Andrea Viazzo, Giovanni Malacrida, Daniela Mazzaccaro, Giovanni Meola, Alfredo Modafferi, Giovanni Nano, Maria Teresa Occhiuto, Paolo Righini, Silvia Stegher, Stefano Chiarandini, Filippo Griselli, Sandro Lepidi, Fabio Pozzi Mucelli, Marcello Naccarato, Mario D'Oria, Barbara Ziani, Andrea Stella, Mortalla Dieng, Gianluca Faggioli, Mauro Gargiulo, Sergio Palermo, Rodolfo Pini, Giovanni Maria Puddu, Andrea Vacirca, Domenico Angiletta, Claudio Desantis, Davide Marinazzo, Giovanni Mastrangelo, Guido Regina, Raffaele Pulli, Paolo Bianchi, Lea Cireni, Elisabetta Coppi, Rocco Pizzirusso, Filippo Scalise, Giovanni Sorropago, Valerio Tolva, Valeria Caso, Enrico Cieri, Paola DeRango, Luca Farchioni, Giacomo Isernia, Massimo Lenti, Gian Battista Parlani, Guglielmo Pupo, Grazia Pula, Gioele Simonte, Fabio Verzini, Federico Carimati, Maria Luisa Delodovici, Federico Fontana, Gabriele Piffaretti, Matteo Tozzi, Efrem Civilini, Giorgio Poletto, Bernhard Reimers, Barbara Praquin, Sonia Ronchey, Laura Capoccia, Wassim Mansour, Enrico Sbarigia, Francesco Speziale, Pasqualino Sirignano, Danilo Toni, Roberto Galeotti, Vincenzo Gasbarro, Francesco Mascoli, Tiberio Rocca, Elpiniki Tsolaki, Giulia Bernardini, Ester DeMarco, Alessia Giaquinta, Francesco Patti, Massimiliano Veroux, Pierfrancesco Veroux, Carla Virgilio, Nicola Mangialardi, Matteo Orrico, Vincenzo Di Lazzaro, Nunzio Montelione, Francesco Spinelli, Francesco Stilo, Carlo Cernetti, Sandro Irsara, Giuseppe Maccarrone, Diego Tonello, Adriana Visonà, Beniamino Zalunardo, Emiliano Chisci, Stefano Michelagnoli, Nicola Troisi, Maela Masato, Massimo Dei Negri, Andrea Pacchioni, Salvatore Saccà, Giovanni Amatucci, Alfredo Cannizzaro, Federico Accrocca, Cesare Ambrogi, Renzo Barbazza, Giustino Marcucci, Andrea Siani, Guido Bajardi, Giovanni Savettieri, Angelo Argentieri, Riccardo Corbetta, Attilio Odero, Pietro Quaretti, Federico Z Thyrion, Alessandro Cappelli, Domenico Benevento, Gianmarco De Donato, Maria Agnese Mele, Giancarlo Palasciano, Daniela Pieragalli, Alessandro Rossi, Carlo Setacci, Francesco Setacci, Domenico Palombo, Maria Cecilia Perfumo, Edoardo Martelli, Aldo Paolucci, Santi Trimarchi, Viviana Grassi, Luigi Grimaldi, Giuliana La Rosa, Domenico Mirabella, Matteo Scialabba, Leonildo Sichel, Costantino L D'Angelo, Gian Franco Fadda, Holta Kasemi, Mario Marino, Francesco Burzotta, Francesco Alberto Codispoti, Angela Ferrante, Giovanni Tinelli, Yamume Tshomba, Claudio Vincenzoni, Deborah Amis, Dawn Anderson, Martin Catterson, Mike Clarke, Michelle Davis, Anand Dixit, Alexander Dyker, Gary Ford, Ralph Jackson, Sreevalsan Kappadath, David Lambert, Tim Lees, Stephen Louw, James McCaslin, Noala Parr, Rebecca Robson, Gerard Stansby, Lucy Wales, Vera Wealleans, Lesley Wilson, Michael Wyatt, Hardeep Baht, Ibrahim Balogun, Ilse Burger, Tracy Cosier, Linda Cowie, Gunaratnam Gunathilagan, David Hargroves, Robert Insall, Sally Jones, Hannah Rudenko, Natasha Schumacher, Jawaharlal Senaratne, George Thomas, Audrey Thomson, Tom Webb, Ellen Brown, Bernard Esisi, Ali Mehrzad, Shane MacSweeney, Norman McConachie, Alison Southam, Wayne Sunman, Ahmed Abdul-Hamiq, Jenny Bryce, Ian Chetter, Duncan Ettles, Raghuram Lakshminarayan, Kim Mitchelson, Christopher Rhymes, Graham Robinson, Paul Scott, Alison Vickers, Ray Ashleigh, Stephen Butterfield, Ed Gamble, Jonathan Ghosh, Charles N McCollum, Mark Welch, Sarah Welsh, Leszek Wolowczyk, Mary Donnelly, Stephen D'Souza, Anselm A Egun, Bindu Gregary, Thomas Joseph, Christine Kelly, Shuja Punekar, M Asad Rahi, Sonia Raj, Dare Seriki, George Thomson, James Brown, Ragunath Durairajan, Iris Grunwald, Paul Guyler, Paula Harman, Matthew Jakeways, Christopher Khuoge, Ashish Kundu, Thayalini Loganathan, Nisha Menon, Raji O Prabakaran, Devesh Sinha, Vicky Thompson, Sharon Tysoe, Dennis Briley, Chris Darby, Linda Hands, Dominic Howard, Wilhelm Kuker, Ursula Schulz, Rachel Teal, David Barer, Andrew Brown, Susan Crawford, Paul Dunlop, Ramesh Krishnamurthy, Nikhil Majmudar, Duncan Mitchell, Min P Myint, Richard O'Brien, Janice O'Connell, Naweed Sattar, Shanmugam Vetrivel, Jonathan Beard, Trevor Cleveland, Peter Gaines, John Humphreys, Alison Jenkins, Craig King, Daniel Kusuma, Ralph Lindert, Robbie Lonsdale, Raj Nair, Shah Nawaz, Faith Okhuoya, Douglas Turner, Graham Venables, Paul Dorman, Andrea Hughes, Deborah Jones, David Mendelow, Helen Rodgers, Aidas Raudoniitis, Peter Enevoldson, Hans Nahser, Imelda O'Brien, Francesco Torella, Dave Watling, Richard White, Pauline Brown, Dipankar Dutta, Lorraine Emerson, Paula Hilltout, Sachin Kulkarni, Jackie Morrison, Keith Poskitt, Fiona Slim, Sarah Smith, Amanda Tyler, Joanne Waldron, Mark Whyman, Milda Bajoriene, Lucy Baker, Amanda Colston, Bekky Eliot-Jones, Gita Gramizadeh, Catherine Lewis-Clarke, Laura McCafferty, Deborah Oliver, Debbie Palmer, Abhijeet Patil, Suzannah Pegler, Gopi Ramadurai, Aisling Roberts, Tracey Sargent, Shivaprasad Siddegowda, Ravi Singh-Ranger, Akintunde Williams, Lucy Williams, Steve Windebank, Tadas Zuromskis, Lanka Alwis, Jane Angus, Asaipillai Asokanathan, Caroline Fornolles, Diana Hardy, Sophy Hunte, Frances Justin, Duke Phiri, Marie Mitabouana-Kibou, Lakshmanan Sekaran, Sakthivel Sethuraman, Margaret L Tate, Joyce Akyea-Mensah, Stephen Ball, Angela Chrisopoulou, Elizabeth Keene, Alison Phair, Steven Rogers, John V Smyth, Colin Bicknell, Jeremy Chataway, Nicholas Cheshire, Andrew Clifton, Caroline Eley, Richard Gibbs, Mohammad Hamady, Beth Hazel, Alex James, Michael Jenkins, Nyma Khanom, Austin Lacey, Maz Mireskandari, Joanna O'Reilly, Antony Pereira, Tina Sachs, John Wolfe, Philip Davey, Gill Rogers, Gemma Smith, Gareth Tervit, Ian Nichol, Andrew Parry, Gavin Young, Simon Ashley, James Barwell, Francis Dix, Azlisham M Nor, Chris Parry, Angela Birt, Paul Davies, Jim George, Anne Graham, Leon Jonker, Nicci Kelsall, Caroline Potts, Toni Wilson, Jamie Crinnion, Larissa Cuenoud, Nikola Aleksic, Srdan Babic, Nenad Ilijevski, Đorde Radak, Dragan Sagic, Slobodan Tanaskovic, Momcilo Colic, Vladimir Cvetic, Lazar Davidovic, Dejana R Jovanovic, Igor Koncar, Perica Mutavdžic, Miloš Sladojevic, Ivan Tomic, Eike S Debus, Ulrich Grzyska, Dagmar Otto, Götz Thomalla, Jessica Barlinn, Johannes Gerber, Kathrin Haase, Christian Hartmann, Stefan Ludwig, Volker Pütz, Christian Reeps, Christine Schmidt, Norbert Weiss, Sebastian Werth, Simon Winzer, Janine Gemper, Albrecht Günther, Bianka Heiling, Elisabeth Jochmann, Panagiota Karvouniari, Carsten Klingner, Thomas Mayer, Julia Schubert, Friederike Schulze-Hartung, Jürgen Zanow, Yvonne Bausback, Franka Borger, Spiridon Botsios, Daniela Branzan, Sven Bräunlich, Henryk Hölzer, Janin Lenzer, Christopher Piorkowski, Nadine Richter, Johannes Schuster, Dierk Scheinert, Andrej Schmidt, Holger Staab, Matthias Ulrich, Martin Werner, Hermann Berger, Gábor Biró, Hans-Henning Eckstein, Michael Kallmayer, Kornelia Kreiser, Alexander Zimmermann, Bärbel Berekoven, Klaus Frerker, Vera Gordon, Giovanni Torsello, Sebastian Arnold, Cora Dienel, Martin Storck, Bernhard Biermaier, Hans Martin Gissler, Christof Klötzsch, Tomas Pfeiffer, Ralph Schneider, Leander Söhl, Michael Wennrich, Angelika Alonso, Michael Keese, Christoph Groden, Andreas Cöster, Andreas Engelhardt, Christoph-Maria Ratusinski, Bengt Berg, Martin Delle, Johan Formgren, Peter Gillgren, Lotta Jarl, Torbjörn B Kall, Peter Konrad, Niklas Nyman, Claes Skiöldebrand, Johnny Steuer, Rabbe Takolander, Jonas Malmstedt, Stefan Acosta, Katarina Björses, Kerstin Brandt, Nuno Dias, Anders Gottsäter, Jan Holst, Thorarinn Kristmundsson, Tobias Kühme, Tilo Kölbel, Bengt Lindblad, Mats Lindh, Martin Malina, Tomas Ohrlander, Tim Resch, Viola Rönnle, Björn Sonesson, Margareta Warvsten, Zbigniew Zdanowski, Erik Campbell, Per Kjellin, Hans Lindgren, Johan Nyberg, Björn Petersen, Gunnar Plate, Håkan Pärsson, Peter Qvarfordt, Pavel Ignatenko, Andrey Karpenko, Vladimir Starodubtsev, Mikhail A Chernyavsky, Maria S Golovkova, Boris B Komakha, Nikolay N Zherdev, Andrey Belyasnik, Pavel Chechulov, Dmitry Kandyba, Igor Stepanishchev, Csaba Csobay-Novák, Edit Dósa, László Entz, Balázs Nemes, Zoltán Szeberin, Pál Barzó, Mihaly Bodosi, Eniko Fákó, Béla Fülöp, Tamás Németh, Szilárd Pazdernyik, Krisztina Skoba, Erika Vörös, Eleni Chatzinikou, Athanasios Giannoukas, Christos Karathanos, Stylianos Koutsias, Georgios Kouvelos, Miltiadis Matsagkas, Styliani Ralli, Christos Rountas, Nikolaos Rousas, Konstantinos Spanos, Elias Brountzos, John D Kakisis, Andreas Lazaris, Konstantinos G Moulakakis, Leonidas Stefanis, Georgios Tsivgoulis, Spyros Vasdekis, Constantine N Antonopoulos, Ion Bellenis, Dimitrios Maras, Antonios Polydorou, Victoria Polydorou, Antonios Tavernarakis, Nikolaos Ioannou, Maria Terzoudi, Miltos Lazarides, Michalis Mantatzis, Kostas Vadikolias, Lukasz Dzieciuchowicz, Marcin Gabriel, Zbigniew Krasinski, Grzegorz Oszkinis, Fryderyk Pukacki, Maciej Slowinski, Michal-Goran Stanišic, Ryszard Staniszewski, Jolanta Tomczak, Maciej Zielinski, Piotr Myrcha, Dorota Rózanski, Stanislaw Drelichowski, Wojciech Iwanowski, Katarzyna Koncewicz, Pawel Bialek, Zbigniew Biejat, Wojciech Czepel, Anna Czlonkowska, Anatol Dowzenko, Julia Jedrzejewska, Adam Kobayashi, Jerzy Leszczynski, Andrzej Malek, Jerzy Polanski, Robert Proczka, Maciej Skorski, Mieczyslaw Szostek, Piotr Andziak, Maciej Dratwicki, Robert Gil, Miroslaw Nowicki, Jaroslaw Pniewski, Jaroslaw Rzezak, Piotr Seweryniak, Pawel Dabek, Michal Juszynski, Grzegorz Madycki, Bartosz Pacewski, Witold Raciborski, Piotr Slowinski, Walerian Staszkiewicz, Martin Bombic, Vladimír Chlouba, Jirí Fiedler, Karel Hes, Petr Koštál, Jindrich Sova, Zdenek Kríž, Mojmír Prívara, Michal Reif, Robert Staffa, Robert Vlachovský, Bohuslav Vojtíšek, Tomáš Hrbác, Martin Kuliha, Václav Procházka, Martin Roubec, David Školoudík, David Netuka, Anna Šteklácová, Vladimír Beneš III, Pavel Buchvald, Ladislav Endrych, Miroslav Šercl, Walter Campos Jr, Ivan B Casella, Nelson de Luccia, André E V Estenssoro, Calógero Presti, Pedro Puech-Leão, Celso R B Neves, Erasmo S da Silva, Cid J Sitrângulo Jr, José A T Monteiro, Gisela Tinone, Marcelo Bellini Dalio, Edwaldo E Joviliano, Octávio M Pontes Neto, Mauricio Serra Ribeiro, Patrick Cras, Jeroen M H Hendriks, Mieke Hoppenbrouwers, Patrick Lauwers, Caroline Loos, Laetitia Yperzeele, Mia Geenens, Dimitri Hemelsoet, Isabelle van Herzeele, Frank Vermassen, Parla Astarci, Frank Hammer, Valérie Lacroix, André Peeters, Robert Verhelst, Silvana Cirelli, Pol Dormal, Annelies Grimonprez, Bart Lambrecht, Philipe Lerut, Eddy Thues, Guy De Koster, Quentin Desiron, Alain Maertens de Noordhout, Danielle Malmendier, Mireille Massoz, Georges Saad, Marc Bosiers, Joren Callaert, Koen Deloose, Estrella Blanco Cañibano, Beatriz García Fresnillo, Mercedes Guerra Requena, Pilar C Morata Barrado, Miguel Muela Méndez, Antonio Yusta Izquierdo, Fernando Aparici Robles, Paula Blanes Orti, Luis García Dominguez, Rafael Martínez López, Manuel Miralles Hernández, José I Tembl Ferrairo, Ángel Chamorro, Juan Macho, Víctor Obach, Vincent Riambau, Luis San Román, Frank J Ahlhelm, Kristine Blackham, Stefan Engelter, Thomas Eugster, Henrik Gensicke, Lorenz Gürke, Philippe Lyrer, Luigi Mariani, Marina Maurer, Edin Mujagic, Mandy Müller, Marios Psychogios, Peter Stierli, Christoph Stippich, Christopher Traenka, Thomas Wolff, Benjamin Wagner, Martina M Wiegert, Sandra Clarke, Michael Diepers, Ernst Gröchenig, Philipp Gruber, Andrej Isaak, Timo Kahles, Regula Marti, Krassen Nedeltchev, Luca Remonda, Nadir Tissira, Martina Valença Falcão, Gert J de Borst, Rob H Lo, Frans L Moll, Raechel Toorop, Bart H van der Worp, Evert J Vonken, Jaap L Kappelle, Ommid Jahrome, Floris Vos, Wouter Schuiling, Hendrik van Overhagen, Rudolf W M Keunen, Bob Knippenberg, Jan J Wever, Jan W Lardenoije, Michel Reijnen, Luuk Smeets, Steven van Sterkenburg, Gustav Fraedrich, Elke Gizewski, Ingrid Gruber, Michael Knoflach, Stefan Kiechl, Barbara Rantner, Timur Abdulamit, Patrice Bergeron, Raymond Padovani, Jean-Christophe Trastour, Jean-Marie Cardon, Anne Le Gallou-Wittenberg, Eric Allaire, Jean-Pierre Becquemin, Frédéric Cochennec-Paliwoda, Pascal Desgranges, Hassan Hosseini, Hicham Kobeiter, Jean Marzelle, Mohammed A Almekhlafi, Simerpreet Bal, Phillip A Barber, Shelagh B Coutts, Andrew M Demchuk, Muneer Eesa, Michelle Gillies, Mayank Goyal, Michael D Hill, Mark E Hudon, Anitha Jambula, Carol Kenney, Gary Klein, Marie McClelland, Alim Mitha, Bijoy K Menon, William F Morrish, Steven Peters, Karla J Ryckborst, Greg Samis, Supriya Save, Eric E Smith, Peter Stys, Suresh Subramaniam, Garnette R Sutherland, Tim Watson, John H Wong, L Zimmel, Vojko Flis, Jože Matela, Kazimir Miksic, Franko Milotic, Božidar Mrdja, Barbara Stirn, Erih Tetickovic, Mladen Gasparini, Anton Grad, Ingrid Kompara, Zoren Miloševic, Veronika Palmiste, Toomas Toomsoo, Balzhan Aidashova, Nursultan Kospanov, Roman Lyssenko, Daulet Mussagaliev, Rafi Beyar, Aaron Hoffman, Tony Karram, Arthur Kerner, Eugenia Nikolsky, Samy Nitecki, Silva Andonova, Chavdar Bachvarov, Vesko Petrov, Ivan Cvjetko, Vinko Vidjak, Damir Halužan, Mladen Petrunic, Bao Liu, Chang-Wei Liu, Daniel Bartko, Peter Beno, František Rusnák, Kamil Zelenák, Masayuki Ezura, Takashi Inoue, Naoto Kimura, Ryushi Kondo, Yasushi Matsumoto, Hiroaki Shimizu, Hidenori Endo, Eisuke Furui, Søren Bakke, Kristen Krohg-Sørensen, Terje Nome, Mona Skjelland, Bjørn Tennøe, João Albuquerque e Castro, Gonçalo Alves, Frederico Bastos Gonçalves, José de Aragão Morais, Ana C Garcia, Hugo Valentim, Leonor Vasconcelos, Fernando Belcastro, Fernando Cura, Patricio Zaefferer, Foad Abd-Allah, Mohamed H Eldessoki, Hussein Heshmat Kassem, Haytham Soliman Gharieb, Mary P Colgan, Syed N Haider, Joe Harbison, Prakash Madhavan, Dermot Moore, Gregor Shanik, Viviane Kazan, Munier Nazzal, Vicki Ramsey-Williams, ACST-2 Collaborative Group, Group, ACST-2 Collaborative, Halliday A., Bulbulia R., Bonati L.H., Chester J., Cradduck-Bamford A., Peto R., Pan H., Potter J., Henning Eckstein H., Farrell B., Flather M., Mansfield A., Mihaylova B., Rahimi K., Simpson D., Thomas D., Sandercock P., Gray R., Molyneux A., Shearman C.P., Rothwell P., Belli A., Herrington W., Judge P., Leopold P., Mafham M., Gough M., Cao P., MacDonald S., Bari V., Berry C., Bradshaw S., Brudlo W., Clarke A., Cox R., Fathers S., Gaba K., Gray M., Hayter E., Holliday C., Kurien R., Lay M., le Conte S., McManus J., Madgwick Z., Morris D., Munday A., Pickworth S., Ostasz W., Poorthuis M., Richards S., Teixeira L., Tochlin S., Tully L., Wallis C., Willet M., Young A., Casana R., Malloggi C., Odero A., Silani V., Parati G., Malchiodi G., Malferrari G., Strozzi F., Tusini N., Vecchiati E., Coppi G., Lauricella A., Moratto R., Silingardi R., Veronesi J., Zini A., Ferrero E., Ferri M., Gaggiano A., Labate C., Nessi F., Psacharopulo D., Viazzo A., Malacrida G., Mazzaccaro D., Meola G., Modafferi A., Nano G., Occhiuto M.T., Righini P., Stegher S., Chiarandini S., Griselli F., Lepidi S., Pozzi Mucelli F., Naccarato M., D'Oria M., Ziani B., Stella A., Dieng M., Faggioli G., Gargiulo M., Palermo S., Pini R., Puddu G.M., Vacirca A., Angiletta D., Desantis C., Marinazzo D., Mastrangelo G., Regina G., Pulli R., Bianchi P., Cireni L., Coppi E., Pizzirusso R., Scalise F., Sorropago G., Tolva V., Caso V., Cieri E., DeRango P., Farchioni L., Isernia G., Lenti M., Parlani G.B., Pupo G., Pula G., Simonte G., Verzini F., Carimati F., Delodovici M.L., Fontana F., Piffaretti G., Tozzi M., Civilini E., Poletto G., Reimers B., Praquin B., Ronchey S., Capoccia L., Mansour W., Sbarigia E., Speziale F., Sirignano P., Toni D., Galeotti R., Gasbarro V., Mascoli F., Rocca T., Tsolaki E., Bernardini G., DeMarco E., Giaquinta A., Patti F., Veroux M., Veroux P., Virgilio C., Mangialardi N., Orrico M., Di Lazzaro V., Montelione N., Spinelli F., Stilo F., Cernetti C., Irsara S., Maccarrone G., Tonello D., Visona A., Zalunardo B., Chisci E., Michelagnoli S., Troisi N., Masato M., Dei Negri M., Pacchioni A., Sacca S., Amatucci G., Cannizzaro A., Accrocca F., Ambrogi C., Barbazza R., Marcucci G., Siani A., Bajardi G., Savettieri G., Argentieri A., Corbetta R., Quaretti P., Thyrion F.Z., Cappelli A., Benevento D., De Donato G., Mele M.A., Palasciano G., Pieragalli D., Rossi A., Setacci C., Setacci F., Palombo D., Perfumo M.C., Martelli E., Paolucci A., Trimarchi S., Grassi V., Grimaldi L., La Rosa G., Mirabella D., Scialabba M., Sichel L., D'Angelo C.L., Fadda G.F., Kasemi H., Marino M., Burzotta F., Codispoti F.A., Ferrante A., Tinelli G., Tshomba Y., Vincenzoni C., Amis D., Anderson D., Catterson M., Clarke M., Davis M., Dixit A., Dyker A., Ford G., Jackson R., Kappadath S., Lambert D., Lees T., Louw S., McCaslin J., Parr N., Robson R., Stansby G., Wales L., Wealleans V., Wilson L., Wyatt M., Baht H., Balogun I., Burger I., Cosier T., Cowie L., Gunathilagan G., Hargroves D., Insall R., Jones S., Rudenko H., Schumacher N., Senaratne J., Thomas G., Thomson A., Webb T., Brown E., Esisi B., Mehrzad A., MacSweeney S., McConachie N., Southam A., Sunman W., Abdul-Hamiq A., Bryce J., Chetter I., Ettles D., Lakshminarayan R., Mitchelson K., Rhymes C., Robinson G., Scott P., Vickers A., Ashleigh R., Butterfield S., Gamble E., Ghosh J., McCollum C.N., Welch M., Welsh S., Wolowczyk L., Donnelly M., D'Souza S., Egun A.A., Gregary B., Joseph T., Kelly C., Punekar S., Rahi M.A., Raj S., Seriki D., Thomson G., Brown J., Durairajan R., Grunwald I., Guyler P., Harman P., Jakeways M., Khuoge C., Kundu A., Loganathan T., Menon N., Prabakaran R.O., Sinha D., Thompson V., Tysoe S., Briley D., Darby C., Hands L., Howard D., Kuker W., Schulz U., Teal R., Barer D., Brown A., Crawford S., Dunlop P., Krishnamurthy R., Majmudar N., Mitchell D., Myint M.P., O'Brien R., O'Connell J., Sattar N., Vetrivel S., Beard J., Cleveland T., Gaines P., Humphreys J., Jenkins A., King C., Kusuma D., Lindert R., Lonsdale R., Nair R., Nawaz S., Okhuoya F., Turner D., Venables G., Dorman P., Hughes A., Jones D., Mendelow D., Rodgers H., Raudoniitis A., Enevoldson P., Nahser H., O'Brien I., Torella F., Watling D., White R., Brown P., Dutta D., Emerson L., Hilltout P., Kulkarni S., Morrison J., Poskitt K., Slim F., Smith S., Tyler A., Waldron J., Whyman M., Bajoriene M., Baker L., Colston A., Eliot-Jones B., Gramizadeh G., Lewis-Clarke C., McCafferty L., Oliver D., Palmer D., Patil A., Pegler S., Ramadurai G., Roberts A., Sargent T., Siddegowda S., Singh-Ranger R., Williams A., Williams L., Windebank S., Zuromskis T., Alwis L., Angus J., Asokanathan A., Fornolles C., Hardy D., Hunte S., Justin F., Phiri D., Mitabouana-Kibou M., Sekaran L., Sethuraman S., Tate M.L., Akyea-Mensah J., Ball S., Chrisopoulou A., Keene E., Phair A., Rogers S., Smyth J.V., Bicknell C., Chataway J., Cheshire N., Clifton A., Eley C., Gibbs R., Hamady M., Hazel B., James A., Jenkins M., Khanom N., Lacey A., Mireskandari M., O'Reilly J., Pereira A., Sachs T., Wolfe J., Davey P., Rogers G., Smith G., Tervit G., Nichol I., Parry A., Young G., Ashley S., Barwell J., Dix F., Nor A.M., Parry C., Birt A., Davies P., George J., Graham A., Jonker L., Kelsall N., Potts C., Wilson T., Crinnion J., Cuenoud L., Aleksic N., Babic S., Ilijevski N., Radak, Sagic D., Tanaskovic S., Colic M., Cvetic V., Davidovic L., Jovanovic D.R., Koncar I., Mutavdzic P., Sladojevic M., Tomic I., Debus E.S., Grzyska U., Otto D., Thomalla G., Barlinn J., Gerber J., Haase K., Hartmann C., Ludwig S., Putz V., Reeps C., Schmidt C., Weiss N., Werth S., Winzer S., Gemper J., Gunther A., Heiling B., Jochmann E., Karvouniari P., Klingner C., Mayer T., Schubert J., Schulze-Hartung F., Zanow J., Bausback Y., Borger F., Botsios S., Branzan D., Braunlich S., Holzer H., Lenzer J., Piorkowski C., Richter N., Schuster J., Scheinert D., Schmidt A., Staab H., Ulrich M., Werner M., Berger H., Biro G., Eckstein H.-H., Kallmayer M., Kreiser K., Zimmermann A., Berekoven B., Frerker K., Gordon V., Torsello G., Arnold S., Dienel C., Storck M., Biermaier B., Gissler H.M., Klotzsch C., Pfeiffer T., Schneider R., Sohl L., Wennrich M., Alonso A., Keese M., Groden C., Coster A., Engelhardt A., Ratusinski C.-M., Berg B., Delle M., Formgren J., Gillgren P., Jarl L., Kall T.B., Konrad P., Nyman N., Skioldebrand C., Steuer J., Takolander R., Malmstedt J., Acosta S., Bjorses K., Brandt K., Dias N., Gottsater A., Holst J., Kristmundsson T., Kuhme T., Kolbel T., Lindblad B., Lindh M., Malina M., Ohrlander T., Resch T., Ronnle V., Sonesson B., Warvsten M., Zdanowski Z., Campbell E., Kjellin P., Lindgren H., Nyberg J., Petersen B., Plate G., Parsson H., Qvarfordt P., Ignatenko P., Karpenko A., Starodubtsev V., Chernyavsky M.A., Golovkova M.S., Komakha B.B., Zherdev N.N., Belyasnik A., Chechulov P., Kandyba D., Stepanishchev I., Csobay-Novak C., Dosa E., Entz L., Nemes B., Szeberin Z., Barzo P., Bodosi M., Fako E., Fulop B., Nemeth T., Pazdernyik S., Skoba K., Voros E., Chatzinikou E., Giannoukas A., Karathanos C., Koutsias S., Kouvelos G., Matsagkas M., Ralli S., Rountas C., Rousas N., Spanos K., Brountzos E., Kakisis J.D., Lazaris A., Moulakakis K.G., Stefanis L., Tsivgoulis G., Vasdekis S., Antonopoulos C.N., Bellenis I., Maras D., Polydorou A., Polydorou V., Tavernarakis A., Ioannou N., Terzoudi M., Lazarides M., Mantatzis M., Vadikolias K., Dzieciuchowicz L., Gabriel M., Krasinski Z., Oszkinis G., Pukacki F., Slowinski M., Stanisic M.-G., Staniszewski R., Tomczak J., Zielinski M., Myrcha P., Rozanski D., Drelichowski S., Iwanowski W., Koncewicz K., Bialek P., Biejat Z., Czepel W., Czlonkowska A., Dowzenko A., Jedrzejewska J., Kobayashi A., Leszczynski J., Malek A., Polanski J., Proczka R., Skorski M., Szostek M., Andziak P., Dratwicki M., Gil R., Nowicki M., Pniewski J., Rzezak J., Seweryniak P., Dabek P., Juszynski M., Madycki G., Pacewski B., Raciborski W., Slowinski P., Staszkiewicz W., Bombic M., Chlouba V., Fiedler J., Hes K., Kostal P., Sova J., Kriz Z., Privara M., Reif M., Staffa R., Vlachovsky R., Vojtisek B., Hrbac T., Kuliha M., Prochazka V., Roubec M., Skoloudik D., Netuka D., Steklacova A., Benes III V., Buchvald P., Endrych L., Sercl M., Campos W., Casella I.B., de Luccia N., Estenssoro A.E.V., Presti C., Puech-Leao P., Neves C.R.B., da Silva E.S., Sitrangulo C.J., Monteiro J.A.T., Tinone G., Bellini Dalio M., Joviliano E.E., Pontes Neto O.M., Serra Ribeiro M., Cras P., Hendriks J.M.H., Hoppenbrouwers M., Lauwers P., Loos C., Yperzeele L., Geenens M., Hemelsoet D., van Herzeele I., Vermassen F., Astarci P., Hammer F., Lacroix V., Peeters A., Verhelst R., Cirelli S., Dormal P., Grimonprez A., Lambrecht B., Lerut P., Thues E., De Koster G., Desiron Q., Maertens de Noordhout A., Malmendier D., Massoz M., Saad G., Bosiers M., Callaert J., Deloose K., Blanco Canibano E., Garcia Fresnillo B., Guerra Requena M., Morata Barrado P.C., Muela Mendez M., Yusta Izquierdo A., Aparici Robles F., Blanes Orti P., Garcia Dominguez L., Martinez Lopez R., Miralles Hernandez M., Tembl Ferrairo J.I., Chamorro A., Macho J., Obach V., Riambau V., San Roman L., Ahlhelm F.J., Blackham K., Engelter S., Eugster T., Gensicke H., Gurke L., Lyrer P., Mariani L., Maurer M., Mujagic E., Muller M., Psychogios M., Stierli P., Stippich C., Traenka C., Wolff T., Wagner B., Wiegert M.M., Clarke S., Diepers M., Grochenig E., Gruber P., Isaak A., Kahles T., Marti R., Nedeltchev K., Remonda L., Tissira N., Valenca Falcao M., de Borst G.J., Lo R.H., Moll F.L., Toorop R., van der Worp B.H., Vonken E.J., Kappelle J.L., Jahrome O., Vos F., Schuiling W., van Overhagen H., Keunen R.W.M., Knippenberg B., Wever J.J., Lardenoije J.W., Reijnen M., Smeets L., van Sterkenburg S., Fraedrich G., Gizewski E., Gruber I., Knoflach M., Kiechl S., Rantner B., Abdulamit T., Bergeron P., Padovani R., Trastour J.-C., Cardon J.-M., Le Gallou-Wittenberg A., Allaire E., Becquemin J.-P., Cochennec-Paliwoda F., Desgranges P., Hosseini H., Kobeiter H., Marzelle J., Almekhlafi M.A., Bal S., Barber P.A., Coutts S.B., Demchuk A.M., Eesa M., Gillies M., Goyal M., Hill M.D., Hudon M.E., Jambula A., Kenney C., Klein G., McClelland M., Mitha A., Menon B.K., Morrish W.F., Peters S., Ryckborst K.J., Samis G., Save S., Smith E.E., Stys P., Subramaniam S., Sutherland G.R., Watson T., Wong J.H., Zimmel L., Flis V., Matela J., Miksic K., Milotic F., Mrdja B., Stirn B., Tetickovic E., Gasparini M., Grad A., Kompara I., Milosevic Z., Palmiste V., Toomsoo T., Aidashova B., Kospanov N., Lyssenko R., Mussagaliev D., Beyar R., Hoffman A., Karram T., Kerner A., Nikolsky E., Nitecki S., Andonova S., Bachvarov C., Petrov V., Cvjetko I., Vidjak V., Haluzan D., Petrunic M., Liu B., Liu C.-W., Bartko D., Beno P., Rusnak F., Zelenak K., Ezura M., Inoue T., Kimura N., Kondo R., Matsumoto Y., Shimizu H., Endo H., Furui E., Bakke S., Krohg-Sorensen K., Nome T., Skjelland M., Tennoe B., Albuquerque e Castro J., Alves G., Bastos Goncalves F., de Aragao Morais J., Garcia A.C., Valentim H., Vasconcelos L., Belcastro F., Cura F., Zaefferer P., Abd-Allah F., Eldessoki M.H., Heshmat Kassem H., Soliman Gharieb H., Colgan M.P., Haider S.N., Harbison J., Madhavan P., Moore D., Shanik G., Kazan V., Nazzal M., Ramsey-Williams V., and Gargiulo M
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,Time Factor ,medicine.medical_treatment ,Carotid Stenosi ,MEDLINE ,Carotid endarterectomy ,Rate ratio ,Risk Assessment ,Asymptomatic ,law.invention ,Randomized controlled trial ,law ,Risk Factors ,carotid artery stenting (CAS) ,carotid endarterectomy (CEA) ,Stent ,medicine ,Humans ,Carotid Stenosis ,Stroke ,Endarterectomy ,Aged ,Endarterectomy, Carotid ,business.industry ,carotid artery ,Risk Factor ,Articles ,General Medicine ,trial ,medicine.disease ,Settore MED/22 - CHIRURGIA VASCOLARE ,Surgery ,Stenosis ,Treatment Outcome ,Settore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARE ,Female ,Stents ,Human medicine ,medicine.symptom ,business ,Human - Abstract
Summary Background Among asymptomatic patients with severe carotid artery stenosis but no recent stroke or transient cerebral ischaemia, either carotid artery stenting (CAS) or carotid endarterectomy (CEA) can restore patency and reduce long-term stroke risks. However, from recent national registry data, each option causes about 1% procedural risk of disabling stroke or death. Comparison of their long-term protective effects requires large-scale randomised evidence. Methods ACST-2 is an international multicentre randomised trial of CAS versus CEA among asymptomatic patients with severe stenosis thought to require intervention, interpreted with all other relevant trials. Patients were eligible if they had severe unilateral or bilateral carotid artery stenosis and both doctor and patient agreed that a carotid procedure should be undertaken, but they were substantially uncertain which one to choose. Patients were randomly allocated to CAS or CEA and followed up at 1 month and then annually, for a mean 5 years. Procedural events were those within 30 days of the intervention. Intention-to-treat analyses are provided. Analyses including procedural hazards use tabular methods. Analyses and meta-analyses of non-procedural strokes use Kaplan-Meier and log-rank methods. The trial is registered with the ISRCTN registry, ISRCTN21144362. Findings Between Jan 15, 2008, and Dec 31, 2020, 3625 patients in 130 centres were randomly allocated, 1811 to CAS and 1814 to CEA, with good compliance, good medical therapy and a mean 5 years of follow-up. Overall, 1% had disabling stroke or death procedurally (15 allocated to CAS and 18 to CEA) and 2% had non-disabling procedural stroke (48 allocated to CAS and 29 to CEA). Kaplan-Meier estimates of 5-year non-procedural stroke were 2·5% in each group for fatal or disabling stroke, and 5·3% with CAS versus 4·5% with CEA for any stroke (rate ratio [RR] 1·16, 95% CI 0·86–1·57; p=0·33). Combining RRs for any non-procedural stroke in all CAS versus CEA trials, the RR was similar in symptomatic and asymptomatic patients (overall RR 1·11, 95% CI 0·91–1·32; p=0·21). Interpretation Serious complications are similarly uncommon after competent CAS and CEA, and the long-term effects of these two carotid artery procedures on fatal or disabling stroke are comparable. Funding UK Medical Research Council and Health Technology Assessment Programme.
- Published
- 2021
127. Synthesis, growth, thermal, mechanical and optical studies of piperazinium based cupric sulfate (PCS) single crystals: A third order nonlinear optical material.
- Author
-
Mullai, R.U., Kanuru, Sreenadha Rao, Arul Jothi, R., Gopinath, S., and Vetrivel, S.
- Subjects
- *
NONLINEAR optical materials , *SINGLE crystals , *BAND gaps , *NEGATIVE refraction , *MICROHARDNESS testing , *PHOSPHORS - Abstract
A third order nonlinear optical (NLO) good quality Piperazinium based cupric sulfate (PCS) single crystals has been grown successfully from homogeneous solution by slow evaporation technique using double distilled water at room temperature. The average dimensions of the as grown crystals are up to 36 × 30 × 15 m m 3 within a period of 35 days. The grown single crystals were subjected to powder X-ray diffraction (XRD) to confirm the crystalline quality. Single crystals X-ray diffraction represents, the PCS crystal belongs to the monoclinic system (P), with unit cell parameters a = 6.87 Å , b = 10.20 Å , c = 11.92 Å and V = 834 A ° 3. Existence of major functional groups in PCS single crystal has been identified by FTIR analysis. The thermal properties of PCS single crystals were analyzed from TG − DTA curves and the compound is thermally stable up to 134 °C. The UV–vis absorption studies indicate the PCS single crystals are optically transparent up to 60.88 % at 496 n m with the cut-off wavelength 258 n m. From the Tauc's plot optical band gap is estimated to be (E g) 5.30 e V.The extinction coefficient (k) vs. wavelength relation for PCS single crystals have minimum absorption of light around 493 n m. The refractive index (n 0) of PCS single crystals has least value for blue and green light; it is gradually increased till red light. It is supported by reflectance vs. wavelength calculation with high reflectance at same wavelength range. The photoluminescence (PL) emission spectra for as grown crystals represent prominent emission around 440 − 470 n m depicting blue emission with 244 n m excitation wavelength. The electric field response of PCS single crystals has been studies in terms of dielectric constant and dielectric loss as a function of frequency and temperature, the results were discussed. The mechanical stability of the grown crystals at room temperature has investigated with Vicker's micro hardness test and evaluated various mechanical parameters such as H v , K c , σ v and C 11.Hardness number increased with load.PCS single crystals exhibits RISE behavior and belong to soft category. The third order nonlinear optical nature of PCS single crystals was studied using Z − scan technique. The negative nonlinear refractive index (n 2) of the crystals indicates self-defocusing effect. The nonlinear absorption coefficient (β) and third order nonlinear optical susceptibility (χ (3)) were also calculated and discussed from the above technique. • The average dimensions of the PCS crystals are up to 36 × 30 × 15 m m 3 and thermally stable up to 134°C. • The transparency is about 60.88 % with cut-off wavelength 258 n m. • PCS single crystals are wide band gap materials (E g) 5.30 e V , with blue emission arround 440- 470 nm. • PCS single crystals exhibits RISE behavior and belong to soft category. • Negative nonlinear refractive index shows self-defocusing effect of PCS crystals. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
128. Polymorphism in the Drug Transporter Gene ABCB1 as a Potential Disease Modifier in Cortisol-Producing Adrenal Adenomas.
- Author
-
Vogel F, Braun L, Vetrivel S, Zhang R, Zopp S, Oßwald A, Nowak E, Schilbach K, Bidlingmaier M, Zimmermann P, Beuschlein F, Hartmann M, Wudy S, Riester A, and Reincke M
- Subjects
- Humans, Male, Female, Middle Aged, Adult, Cross-Sectional Studies, Adrenocortical Adenoma genetics, Adrenocortical Adenoma metabolism, Polymorphism, Single Nucleotide, Adrenal Gland Neoplasms genetics, Adrenal Gland Neoplasms metabolism, Adenoma genetics, Adenoma metabolism, Aged, Cohort Studies, ATP Binding Cassette Transporter, Subfamily B genetics, Hydrocortisone urine, Hydrocortisone metabolism
- Abstract
Introduction: Endogenous hypercortisolism presents with variable phenotypes. Etiological factors accounting for the level of hypercortisolism or varying severity of associated comorbidities are lacking. Recently, the adrenal ATP-binding cassette B1 (ABCB1) gene was identified as a modulator of glucocorticoid secretion., Objective: To evaluate the effect of ABCB1 polymorphism rs2032582 on steroid metabolome and clinical phenotypes in patients with endogenous hypercortisolism., Methods: In this cross-sectional cohort study, 137 patients prospectively enrolled in the German Cushing's registry were included (41 with ACTH-producing pituitary adenoma, 21 with cortisol-producing adrenal adenoma, and 75 with excluded hypercortisolism). In all patients, ABCB1 polymorphism was analyzed using a TaqMan genotyping assay, glucocorticoid metabolite excretion in 24-hour urine samples was analyzed by gas chromatography-mass spectrometry, and the clinical phenotype was assessed systematically., Results: In patients with cortisol-producing adrenal adenomas, but not in patients with ACTH-producing pituitary adenomas, homozygous major allele GG of ABCB1 polymorphism rs2032582 was associated with higher overall cortisol metabolite secretion (median 13515 [IQR 10347; 25669] µg/24h vs. 9645 [6146; 10732] µg/24h in minor homo- and heterozygotes, p=0.036) and elevated major cortisol metabolites αTHF, THF and THE (9339 [6929; 17789] µg/24h vs. 6288 [4184; 7455] µg/24h, p=0.045). Moreover, these patients showed higher mean arterial pressure (116 [111; 131] mmHg in major homozygotes vs. 105 [96; 112] mmHg in minor homo- and heterozygotes, p=0.036)., Conclusion: The genotype of drug transporter gene ABCB1 rs2032582 polymorphism is associated with the degree of cortisol metabolite secretion in cortisol-producing adrenal adenomas and could, therefore, represent a modifier of disease severity in this context., Competing Interests: The authors declare that they have no conflict of interest., (Thieme. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
129. PPARG dysregulation as a potential molecular target in adrenal Cushing's syndrome.
- Author
-
Vetrivel S, Tamburello M, Oßwald A, Zhang R, Khan A, Jung S, Baker JE, Rainey WE, Nowak E, Altieri B, Detomas M, Watts D, Williams TA, Wielockx B, Beuschlein F, Reincke M, Sbiera S, and Riester A
- Subjects
- Humans, Adrenalectomy methods, Hydrocortisone metabolism, Hyperplasia, PPAR gamma genetics, Cushing Syndrome genetics, Cushing Syndrome surgery, Cushing Syndrome drug therapy
- Abstract
Background: We performed a transcriptomic analysis of adrenal signaling pathways in various forms of endogenous Cushing's syndrome (CS) to define areas of dysregulated and druggable targets., Methodology: Next-generation sequencing was performed on adrenal samples of patients with primary bilateral macronodular adrenal hyperplasia (PBMAH, n=10) and control adrenal samples (n=8). The validation groups included cortisol-producing adenoma (CPA, n=9) and samples from patients undergoing bilateral adrenalectomy for Cushing's disease (BADX-CD, n=8). In vivo findings were further characterized using three adrenocortical cell-lines (NCI-H295R, CU-ACC2, MUC1)., Results: Pathway mapping based on significant expression patterns identified PPARG (peroxisome proliferator-activated receptor gamma) pathway as the top hit. Quantitative PCR (QPCR) confirmed that PPARG (l2fc<-1.5) and related genes - FABP4 (l2fc<-5.5), PLIN1 (l2fc<-4.1) and ADIPOQ (l2fc<-3.3) - were significantly downregulated (p<0.005) in PBMAH. Significant downregulation of PPARG was also found in BADX-CD (l2fc<-1.9, p<0.0001) and CPA (l2fc<-1.4, p<0.0001). In vitro studies demonstrated that the PPARG activator rosiglitazone resulted in decreased cell viability in MUC1 and NCI-H295R (p<0.0001). There was also a significant reduction in the production of aldosterone, cortisol, and cortisone in NCI-H295R and in Dihydrotestosterone (DHT) in MUC1 (p<0.05), respectively., Outcome: This therapeutic effect was independent of the actions of ACTH, postulating a promising application of PPARG activation in endogenous hypercortisolism., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision., (Copyright © 2023 Vetrivel, Tamburello, Oßwald, Zhang, Khan, Jung, Baker, Rainey, Nowak, Altieri, Detomas, Watts, Williams, Wielockx, Beuschlein, Reincke, Sbiera and Riester.)
- Published
- 2023
- Full Text
- View/download PDF
130. Identification of ocular regulatory functions of core histone variant H3.2.
- Author
-
Vetrivel S, Truong DJ, Wurst W, Graw J, and Giesert F
- Subjects
- Animals, Mice, Immunohistochemistry, Mice, Transgenic, Mutation, Histones genetics
- Abstract
The posttranscriptional modifications (PTM) of the Histone H3 family play an important role in ocular system differentiation. However, there has been no study on the nature of specific Histone H3 subtype carrying these modifications. Fortuitously, we had previously identified a dominant small-eye mutant Aey69 mouse with a mutation in the H3.2 encoding Hist2h3c1 gene (Vetrivel et al., 2019). In continuation, in the present study, the role of Histone H3.2 with relation to the microphtalmic Aey69 has been elaborated. Foremost, a transgenic mouse line expressing the fusion protein H3.2-GFP was generated using Crispr/Cas9. The approach was intended to confer a unique tag to the Hist2h3c1 gene which is similar in sequence and encoded protein structure to other histones. The GFP tag was then used for ChIP Seq analysis of the genes regulated by H3.2. The approach revealed ocular specific H3.2 targets including Ephrin family genes. Altered enrichment of H3.2 was found in the mutant Aey69 mouse, specifically around the ligand Efna5 and the receptor Ephb2. The effect of this altered enrichment on Ephrin signaling was further analysed by QPCR and immunohistochemistry. This study identifies Hist2h3c1 encoded H3.2 as an important epigenetic player in ocular development. By binding to specific regions of ocular developmental factors Histone H3.2 facilitates the function of these genes for successful early ocular development., Competing Interests: Declaration of competing interest The authors have nothing to disclose., (Copyright © 2022. Published by Elsevier Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
131. Steroid profiling using liquid chromatography mass spectrometry during adrenal vein sampling in patients with primary bilateral macronodular adrenocortical hyperplasia.
- Author
-
Zhang R, Rubinstein G, Vetrivel S, Kunz S, Vogel F, Bouys L, Bertherat J, Kroiss M, Deniz S, Osswald A, Knösel T, Bidlingmaier M, Sbiera S, Reincke M, and Riester A
- Subjects
- Humans, Chromatography, Liquid, Hyperplasia, Androstenedione, Retrospective Studies, Tandem Mass Spectrometry, Steroids, Androgens, Dehydroepiandrosterone, Hydrocortisone, Cortisone
- Abstract
Introduction: Adrenal vein sampling (AVS) is not a routine procedure in patients with primary bilateral macronodular adrenocortical hyperplasia (PBMAH), but has been used to determine lateralization of cortisol secretion in order to guide decision of unilateral adrenalectomy. Our aim was to characterize the steroid fingerprints in AVS samples of patients with PBMAH and hypercortisolism and to identify a reference hormone for AVS interpretation., Method: Retrospectively, we included 17 patients with PBMAH from the German Cushing's registry who underwent AVS. 15 steroids were quantified in AVS and peripheral blood samples using LC-MS/MS. We calculated lateralization indices and conversion ratios indicative of steroidogenic enzyme activity to elucidate differences between individual adrenal steroidomes and in steroidogenic pathways., Results: Adrenal volume was negatively correlated with peripheral cortisone (r=0.62, p <0.05). 24-hour urinary free cortisol correlated positively with peripheral androgens (rDHEA=0.57, rDHEAS=0.82, rA=0.73, rT=0.54, p <0.05). DHEA was found to be a powerful reference hormone with high selectivity index, which did not correlate with serume cortisol and has a short half-life. All investigated steroids showed lateralization in single patients indicating the heterogenous steroid secretion pattern in patients with PBMAH. The ratios of corticosterone/aldosterone (catalyzed by CYP11B2), androstenedione/dehydroepiandrosterone (catalyzed by HSD3B2) and cortisone/cortisol (catalyzed by HSD11B2) in adrenal vein samples were higher in smaller adrenals ( p <0.05). ARMC5 mutation carriers (n=6) showed lower androstenedione/17-hydroxyprogesterone and higher testosterone/androstenedione ( p <0.05) ratios in peripheral blood, in line with lower peripheral androstenedione concentrations ( p <0.05)., Conclusion: Steroid profiling by LC-MS/MS led us to select DHEA as a candidate reference hormone for cortisol secretion. Lateralization and different steroid ratios showed that each steroid and all three steroidogenic pathways may be affected in PBMAH patients. In patients with germline ARMC5 mutations, the androgen pathway was particularly dysregulated., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Zhang, Rubinstein, Vetrivel, Kunz, Vogel, Bouys, Bertherat, Kroiss, Deniz, Osswald, Knösel, Bidlingmaier, Sbiera, Reincke and Riester.)
- Published
- 2022
- Full Text
- View/download PDF
132. Characterization of Adrenal miRNA-Based Dysregulations in Cushing's Syndrome.
- Author
-
Vetrivel S, Zhang R, Engel M, Oßwald A, Watts D, Chen A, Wielockx B, Sbiera S, Reincke M, and Riester A
- Subjects
- Adrenal Glands metabolism, Adrenalectomy, Adrenocorticotropic Hormone metabolism, Animals, Humans, Hydrocortisone metabolism, Mice, Pituitary ACTH Hypersecretion genetics, Pituitary ACTH Hypersecretion metabolism, Cushing Syndrome classification, Cushing Syndrome genetics, Cushing Syndrome metabolism, MicroRNAs genetics, MicroRNAs metabolism
- Abstract
MiRNAs are important epigenetic players with tissue- and disease-specific effects. In this study, our aim was to investigate the putative differential expression of miRNAs in adrenal tissues from different forms of Cushing’s syndrome (CS). For this, miRNA-based next-generation sequencing was performed in adrenal tissues taken from patients with ACTH-independent cortisol-producing adrenocortical adenomas (CPA), from patients with ACTH-dependent pituitary Cushing’s disease (CD) after bilateral adrenalectomy, and from control subjects. A confirmatory QPCR was also performed in adrenals from patients with other CS subtypes, such as primary bilateral macronodular hyperplasia and ectopic CS. Sequencing revealed significant differences in the miRNA profiles of CD and CPA. QPCR revealed the upregulated expression of miR-1247-5p in CPA and PBMAH (log2 fold change > 2.5, p < 0.05). MiR-379-5p was found to be upregulated in PBMAH and CD (log2 fold change > 1.8, p < 0.05). Analyses of miR-1247-5p and miR-379-5p expression in the adrenals of mice which had been exposed to short-term ACTH stimulation showed no influence on the adrenal miRNA expression profiles. For miRNA-specific target prediction, RNA-seq data from the adrenals of CPA, PBMAH, and control samples were analyzed with different bioinformatic platforms. The analyses revealed that both miR-1247-5p and miR-379-5p target specific genes in the WNT signaling pathway. In conclusion, this study identified distinct adrenal miRNAs as being associated with CS subtypes.
- Published
- 2022
- Full Text
- View/download PDF
133. Circulating microRNA Expression in Cushing's Syndrome.
- Author
-
Vetrivel S, Zhang R, Engel M, Altieri B, Braun L, Osswald A, Bidlingmaier M, Fassnacht M, Beuschlein F, Reincke M, Chen A, Sbiera S, and Riester A
- Subjects
- Adenoma blood, Adult, Biomarkers blood, Cushing Syndrome blood, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Pituitary ACTH Hypersecretion blood, Registries, Retrospective Studies, Adenoma diagnosis, Circulating MicroRNA blood, Cushing Syndrome diagnosis, Pituitary ACTH Hypersecretion diagnosis
- Abstract
Context: Cushing's syndrome (CS) is a rare disease of endogenous hypercortisolism associated with high morbidity and mortality. Diagnosis and classification of CS is still challenging., Objective: Circulating microRNAs (miRNAs) are minimally invasive diagnostic markers. Our aim was to characterize the circulating miRNA profiles of CS patients and to identify distinct profiles between the two major CS subtypes., Methods: We included three groups of patients from the German Cushing's registry: ACTH-independent CS (Cortisol-Producing-Adenoma; CPA), ACTH-dependent pituitary CS (Cushing's Disease; CD), and patients in whom CS had been ruled out (controls). Profiling of miRNAs was performed by next-generation-sequencing (NGS) in serum samples of 15 CS patients (each before and after curative surgery) and 10 controls. Significant miRNAs were first validated by qPCR in the discovery cohort and then in an independent validation cohort of 20 CS patients and 11 controls., Results: NGS identified 411 circulating miRNAs. Differential expression of 14 miRNAs were found in the pre- and postoperative groups. qPCR in the discovery cohort validated 5 of the significant miRNAs from the preoperative group analyses. Only, miR-182-5p was found to be significantly upregulated in the CD group of the validation cohort. Comparing all CS samples as a group with the controls did not reveal any significant differences in expression., Outcome: In conclusion, our study identified miR-182-5p as a possible biomarker for CD, which has to be validated in a prospective cohort. Furthermore, our results suggest that presence or absence of ACTH might be at least as relevant for miRNA expression as hypercortisolism itself., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Vetrivel, Zhang, Engel, Altieri, Braun, Osswald, Bidlingmaier, Fassnacht, Beuschlein, Reincke, Chen, Sbiera and Riester.)
- Published
- 2021
- Full Text
- View/download PDF
134. Mutation in the mouse histone gene Hist2h3c1 leads to degeneration of the lens vesicle and severe microphthalmia.
- Author
-
Vetrivel S, Tiso N, Kügler A, Irmler M, Horsch M, Beckers J, Hladik D, Giesert F, Gailus-Durner V, Fuchs H, Sabrautzki S, Hrabě de Angelis M, and Graw J
- Subjects
- Animals, Crystallins metabolism, Female, Forkhead Transcription Factors metabolism, Gene Expression Regulation, Developmental physiology, Homeodomain Proteins metabolism, Immunohistochemistry, In Situ Hybridization, Ki-67 Antigen metabolism, Lens Diseases embryology, Lens Diseases metabolism, Lens Diseases pathology, Male, Mice, Mice, Inbred C3H, Mice, Inbred C57BL, Microphthalmos embryology, Microphthalmos metabolism, Microphthalmos pathology, Polymorphism, Single Nucleotide, Real-Time Polymerase Chain Reaction, Transcription Factors metabolism, Zebrafish, Gene Knockdown Techniques, Histones genetics, Lens Diseases genetics, Microphthalmos genetics, Mutation
- Abstract
During an ENU (N-ethyl-N-nitrosourea) mutagenesis screen, we observed a dominant small-eye mutant mouse with viable homozygotes. A corresponding mutant line was established and referred to as Aey69 (abnormality of the eye #69). Comprehensive phenotyping of the homozygous Aey69 mutants in the German Mouse Clinic revealed only a subset of statistically significant alterations between wild types and homozygous mutants. The mutation causes microphthalmia without a lens but with retinal hyperproliferation. Linkage was demonstrated to mouse chromosome 3 between the markers D3Mit188 and D3Mit11. Sequencing revealed a 358 A-> C mutation (Ile120Leu) in the Hist2h3c1 gene and a 71 T-> C (Val24Ala) mutation in the Gja8 gene. Detailed analysis of eye development in the homozygous mutant mice documented a perturbed lens development starting from the lens vesicle stage including decreasing expression of crystallins as well as of lens-specific transcription factors like PITX3 and FOXE3. In contrast, we observed an early expression of retinal progenitor cells characterized by several markers including BRN3 (retinal ganglion cells) and OTX2 (cone photoreceptors). The changes in the retina at the early embryonic stages of E11.5-E15.5 happen in parallel with apoptotic processes in the lens at the respective stages. The excessive retinal hyperproliferation is characterized by an increased level of Ki67. The hyperproliferation, however, does not disrupt the differentiation and appearance of the principal retinal cell types at postnatal stages, even if the overgrowing retina covers finally the entire bulbus of the eye. Morpholino-mediated knock-down of the hist2h3ca1 gene in zebrafish leads to a specific perturbation of lens development. When injected into zebrafish zygotes, only the mutant mouse mRNA leads to severe malformations, ranging from cyclopia to severe microphthalmia. The wild-type Hist2h3c1 mRNA can rescue the morpholino-induced defects corroborating its specific function in lens development. Based upon these data, it is concluded that the ocular function of the Hist2h3c1 gene (encoding a canonical H3.2 variant) is conserved throughout evolution. Moreover, the data highlight also the importance of Hist2h3c1 in the coordinated formation of lens and retina during eye development., (Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
135. Crystal structure of 1,4-bis-(3-ammonio-prop-yl)piperazine-1,4-diium bis-[dichromate(VI)].
- Author
-
Vetrivel S, Vinoth E, Mullai RU, Aruljothi R, and NizamMohideen M
- Abstract
The asymmetric unit of the organic-inorganic title salt, (C10H28N4)[Cr2O7]2, comprises one half of an 1,4-bis-(3-ammonio-prop-yl)piperazinediium cation (the other half being generated by the application of inversion symmetry) and a dichromate anion. The piperazine ring of the cation adopts a chair conformation, and the two CrO4 tetra-hedra of the anion are in an almost eclipsed conformation. In the crystal, the cations and anions form a layered arrangement parallel to (001). N-H⋯O hydrogen bonds between the cations and anions and additional C-H⋯O inter-actions lead to the formation of a three-dimensional network structure.
- Published
- 2016
- Full Text
- View/download PDF
136. Combination of driselase and lysing enzyme in one molar potassium chloride is effective for the production of protoplasts from germinated conidia of Fusarium verticillioides.
- Author
-
Ramamoorthy V, Govindaraj L, Dhanasekaran M, Vetrivel S, Kumar KK, and Ebenezar E
- Subjects
- Cell Wall enzymology, Culture Media, Fungal Proteins metabolism, Fusarium ultrastructure, Glycoside Hydrolases metabolism, Potassium Chloride pharmacology, Protoplasts ultrastructure, Spores, Fungal physiology, Spores, Fungal ultrastructure
- Abstract
Various cell wall degrading enzymes and the protoplasting media were evaluated for the production of protoplast in Fusarium verticillioides. Among the various enzymes tested, driselase at 12.5 mg/ml in 1 M KCl protoplasting medium produced the maximum number of protoplast. Next to driselase, lysing enzyme at 10 mg/ml in 1.2 M MgSO4 protoplasting medium was found to be the second best enzyme for the production of protoplast. More interestingly, the combined use of driselase @ 12.5 mg/ml and lysing enzyme @ 10 mg/ml in 1 M KCl exhibited the additive effect on protoplast formation. Germinated conidia of F. verticillioides are the most susceptible fungal material for protoplast production. The use of sucrose at 1.2 M in the regeneration medium supported the maximum regeneration of protoplast. From the present study, we recommend driselase (12.5 mg/ml) and lysing enzyme (10 mg/ml) in 1 M KCl protoplasting medium and germinated conidia of F. verticillioides for the maximum production of protoplasts and 1.2 M sucrose is the best osmoticum for the regeneration of protoplasts., (Copyright © 2015 Elsevier B.V. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
137. Rapid sonochemical synthesis of MCM-41 type benzene-bridged periodic mesoporous organosilicas.
- Author
-
Deka JR, Vetrivel S, Wu HY, Pan YC, Ting CC, Tsai YL, and Kao HM
- Abstract
Benzene-bridged periodic mesoporous organosilicas (PMOs) with the MCM-41 were synthesized by a rapid sonochemical process via co-condensation of tetraethoxysilane (TEOS) and 1,4-bis(triethoxysilyl) benzene (BTEB) under basic conditions within a few minutes using cetyltrimethylammoniumbromide (CTMABr) as a structure-directing agent. The molar ratio of the silicon precursors and the synthesis time were varied in order to investigate their influence on the structural ordering of the materials. The characteristics of the materials were evaluated by X-ray diffraction (XRD), N2-sorption, transmission electron microscopy (TEM) and solid-state NMR spectroscopy. The resultant materials exhibited well-ordered hexagonal mesostructures with surface areas in the range of 602-1237 m(2)/g, pore volumes of 0.37-0.68 cm(3)/g, and pore diameters in the range of 2.5-3.5 nm. Two dimensional (29)Si{(1)H} heteronuclear correlation (HETCOR) NMR spectra confirmed the formation of a single mesophase with various Q (from TEOS) and T (from BTEB) silicon species located randomly within the pore walls due to the co-condensation of BTEB and TEOS, which excluded the possibility of formation of island or two separate phases within such a short synthesis time. The prime advantage of the present synthesis route is that it can effectively reduce the total synthesis time from days to a few minutes, much shorter than the conventional benzene-bridged PMOs synthesis methods., (Copyright © 2013 Elsevier B.V. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
138. A simple one-pot route to mesoporous silicas SBA-15 functionalized with exceptionally high loadings of pendant carboxylic acid groups.
- Author
-
Tsai CT, Pan YC, Ting CC, Vetrivel S, Chiang AS, Fey GT, and Kao HM
- Abstract
Ordered SBA-15 functionalized with a high loading of pendant carboxylate groups has been synthesized via co-condensation of tetraethoxysilane (TEOS) and carboxyethylsilanetriol sodium salt (CES) templated by Pluronic P123 under acidic conditions.
- Published
- 2009
- Full Text
- View/download PDF
139. Retrograde popliteal approach to common femoral vein stenosis in an intravenous drug user with hostile groin: a case report.
- Author
-
Mohamed ZK, Banerjee B, Brown AS, Dunlop P, England SJ, Overbeck K, and Vetrivel S
- Abstract
Intravenous (IV) drug abuse is a common problem in our society. One complication of this practice is venous stenosis, endovascular management of which can be technically challenging especially in patients with a hostile groin. We describe an ipsilateral retrograde popliteal approach in a 26-year-old IV drug user presenting with swelling of the left leg secondary to common femoral vein stenosis. This approach represents the next best method following failed contralateral/cross-bifurcation access and is a safe, convenient alternative offering a "straight run" at the lesion.
- Published
- 2009
- Full Text
- View/download PDF
140. Toxic megacolon complicating Escherichia coli O157 infection.
- Author
-
Nayar DM, Vetrivel S, McElroy J, Pai P, and Koerner RJ
- Subjects
- Adult, Anti-Infective Agents administration & dosage, Antibodies, Bacterial blood, Ciprofloxacin administration & dosage, Colitis microbiology, Colon pathology, Colon surgery, Escherichia coli Infections diagnosis, Escherichia coli Infections drug therapy, Escherichia coli O157 immunology, Female, Gastrointestinal Hemorrhage microbiology, Humans, Immunoglobulin M blood, Megacolon, Toxic surgery, Metronidazole administration & dosage, Treatment Outcome, Escherichia coli Infections complications, Escherichia coli Infections microbiology, Escherichia coli O157 isolation & purification, Hemolytic-Uremic Syndrome etiology, Megacolon, Toxic etiology
- Abstract
Toxic megacolon is a well known complication in inflammatory bowel disease such as ulcerative colitis or Crohn's disease. The development of toxic megacolon as a complication of infectious colitis is rare. However it is recognised as a complication of enteric infections caused by Clostridium difficile, Campylobacter jejuni, Shigella, Salmonella species, Cytomegalovirus and amoebae. We describe a case of necrotising haemorrhagic ileo-colitis in a previously fit and healthy young adult female caused by Escherichia coli O157 where toxic megacolon developed as a complication along with hemolytic uremic syndrome (HUS).
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.